ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)

ClinicalTrials.gov ID: NCT04057573

Public ClinicalTrials.gov record NCT04057573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2): A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo

Study identification

NCT ID
NCT04057573
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
344 participants

Conditions and interventions

Interventions

  • Ruxolitinib cream Drug
  • Vehicle Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2, 2019
Primary completion
Mar 14, 2021
Completion
Sep 30, 2021
Last update posted
Aug 21, 2025

2019 – 2021

United States locations

U.S. sites
34
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
Desert Sky Dermatology Gilbert Arizona 85295
Center For Dermatology Cosmetic and Laser Surgery Fremont California 94538
Uci Beckman Laser Institute and Medical Clinic Irvine California 92617
UCI Health Beckman Laser Institute and Medical Center Irvine California 92697
Vitiligo & Pigmentation Institute of Southern California Los Angeles California 90036
Dermatology Research Associates Los Angeles California 90045
Dermatology Specialists Inc Murrieta California 92562
Dermatology Specialists Inc Oceanside California 92056
Integrative Skin Science and Research Sacramento California 95815
Acrc Studies San Diego California 92119
Central Sooner Research San Diego California 92123
Colorado Medical Research Center Inc Denver Colorado 80210
Advanced Pharma Cr Miami Florida 33147
Leavitt Medical Associates of Florida Ormond Beach Florida 32174
Avita Clinical Research Tampa Florida 33613
Olympian Clinical Research Tampa Florida 33614
Ashira Dermatology Llc Gurnee Illinois 60031
Randall Dermatology of West Lafayette West Lafayette Indiana 47096
Randall Dermatology West Lafayette Indiana 47906
Delricht Clinical Research - Clinedge - Ppds Baton Rouge Baton Rouge Louisiana 70809
Tufts Medical Center Boston Massachusetts 02111
Tufts Medical Center Boston Massachusetts 02116
Metro Boston Clinical Partners Brighton Massachusetts 02135
University of Massachusetts Worcester Massachusetts 01655
Henry Ford Hospital Detroit Michigan 48202
Henry Ford Medical Center Detroit Michigan 48202
Minnesota Clinical Study Center Minneapolis Minnesota 55432
Jdr Dermatology Research Las Vegas Nevada 89148
Northwell Physician Partners New Hyde Park New York 11042
Icahn School of Medicine At Mount Sinai New York New York 10029
Derm Research Center of New York Inc Stony Brook New York 11790
Central Sooner Research Norman Oklahoma 73071
Oregon Medical Research Center Portland Oregon 97223
Clinical Research Partners Llc Richmond Virginia 23220

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04057573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 21, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04057573 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →